These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3119773

  • 1. Anterograde vs. retrograde degeneration of the nucleus basalis medialis in Alzheimer's disease.
    Pearson RC, Powell TP.
    J Neural Transm Suppl; 1987; 24():139-46. PubMed ID: 3119773
    [Abstract] [Full Text] [Related]

  • 2. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Teipel SJ, Flatz WH, Heinsen H, Bokde AL, Schoenberg SO, Stöckel S, Dietrich O, Reiser MF, Möller HJ, Hampel H.
    Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
    [Abstract] [Full Text] [Related]

  • 3. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ.
    Adv Neurol; 1987 Nov; 45():393-7. PubMed ID: 2881448
    [No Abstract] [Full Text] [Related]

  • 4. [Alzheimer's disease and Meynert's nucleus basalis. An anatomo- clinical point of view].
    Brion S, Plas J, Massé G.
    Encephale; 1986 Nov; 12(3):111-4. PubMed ID: 3769856
    [Abstract] [Full Text] [Related]

  • 5. Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease.
    Arendt T, Bigl V, Tennstedt A, Arendt A.
    Neurosci Lett; 1984 Jul 13; 48(1):81-5. PubMed ID: 6472737
    [Abstract] [Full Text] [Related]

  • 6. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas.
    Arendt T, Brückner MK, Bigl V, Marcova L.
    J Comp Neurol; 1995 Jan 09; 351(2):223-46. PubMed ID: 7699112
    [Abstract] [Full Text] [Related]

  • 7. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
    Arai H, Iizuka R.
    Nihon Rinsho; 1988 Jul 09; 46(7):1491-5. PubMed ID: 3221455
    [No Abstract] [Full Text] [Related]

  • 8. The nucleus basalis of Meynert in neurological disease: a quantitative morphological study.
    Rogers JD, Brogan D, Mirra SS.
    Ann Neurol; 1985 Feb 09; 17(2):163-70. PubMed ID: 3883886
    [Abstract] [Full Text] [Related]

  • 9. The afferent connections of the substantia innominata in the monkey, Macaca fascicularis.
    Russchen FT, Amaral DG, Price JL.
    J Comp Neurol; 1985 Dec 01; 242(1):1-27. PubMed ID: 3841131
    [Abstract] [Full Text] [Related]

  • 10. A review of neuropathological and neurochemical correlates of Alzheimer's disease.
    Perry EK, Perry RH.
    Dan Med Bull; 1985 Feb 01; 32 Suppl 1():27-34. PubMed ID: 2859148
    [No Abstract] [Full Text] [Related]

  • 11. The cholinergic deficit in Alzheimer's disease.
    Whitehouse PJ.
    J Clin Psychiatry; 1998 Feb 01; 59 Suppl 13():19-22. PubMed ID: 9771826
    [Abstract] [Full Text] [Related]

  • 12. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease.
    Nakano I, Hirano A.
    Ann Neurol; 1984 May 01; 15(5):415-8. PubMed ID: 6732189
    [Abstract] [Full Text] [Related]

  • 13. Amyloid deposition in the nucleus basalis of Meynert complex: a topographic marker for degenerating cell clusters in Alzheimer's disease.
    Arendt T, Taubert G, Bigl V, Arendt A.
    Acta Neuropathol; 1988 May 01; 75(3):226-32. PubMed ID: 3348080
    [Abstract] [Full Text] [Related]

  • 14. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.
    Pearson RC, Sofroniew MV, Cuello AC, Powell TP, Eckenstein F, Esiri MM, Wilcock GK.
    Brain Res; 1983 Dec 19; 289(1-2):375-9. PubMed ID: 6362777
    [Abstract] [Full Text] [Related]

  • 15. Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer's disease--a hypothesis.
    Förstl H, Levy R, Burns A, Luthert P, Cairns N.
    Pharmacopsychiatry; 1994 Jan 19; 27(1):11-5. PubMed ID: 8159776
    [Abstract] [Full Text] [Related]

  • 16. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. I. Dendritic organisation of the normal human basal forebrain.
    Arendt T, Marcova L, Bigl V, Brückner MK.
    J Comp Neurol; 1995 Jan 09; 351(2):169-88. PubMed ID: 7699111
    [Abstract] [Full Text] [Related]

  • 17. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease.
    Arendt T, Bigl V, Tennstedt A, Arendt A.
    Neuroscience; 1985 Jan 09; 14(1):1-14. PubMed ID: 3974875
    [Abstract] [Full Text] [Related]

  • 18. A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease.
    Mann DM, Yates PO, Marcyniuk B.
    J Neurol Neurosurg Psychiatry; 1984 Feb 09; 47(2):201-3. PubMed ID: 6707659
    [Abstract] [Full Text] [Related]

  • 19. Note on the pathology of the basal nucleus of Meynert in degenerative brain disorders.
    Tagliavini F, Pilleri G.
    Schweiz Arch Neurol Neurochir Psychiatr; 1984 Feb 09; 135(2):277-80. PubMed ID: 6240766
    [No Abstract] [Full Text] [Related]

  • 20. [Morphometric study of the magnocellular basal forebrain system in patients with Alzheimer's disease].
    Kobayashi K, Fukutani Y, Nakamura I, Kawasaki Y, Suzuki M, Yamaguchi N, Nakanishi I.
    No To Shinkei; 1990 Apr 09; 42(4):345-51. PubMed ID: 2390367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.